Capital Impact Advisors, LLC - KYTHERA BIOPHARMACEUTICALS I ownership

KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of KYTHERA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$588,000
-0.3%
7,8360.0%0.30%
+11.6%
Q2 2015$590,000
+50.1%
7,8360.0%0.27%
+49.7%
Q1 2015$393,000
+147.2%
7,836
+71.0%
0.18%
+138.7%
Q4 2014$159,000
+6.0%
4,5820.0%0.08%
Q3 2014$150,000
-14.8%
4,5820.0%0.00%
-100.0%
Q2 2014$176,0004,5820.13%
Other shareholders
KYTHERA BIOPHARMACEUTICALS I shareholders Q4 2014
NameSharesValueWeighting ↓
Palo Alto Investors LP 900,559$33,636,0003.14%
Redmile Group, LLC 557,761$20,777,0002.56%
SENZAR ASSET MANAGEMENT, LLC 79,000$2,951,0002.41%
Aureus Asset Management, LLC 134,465$5,022,0001.36%
REGENTATLANTIC CAPITAL LLC 193,454$7,226,0000.70%
PFM Health Sciences, LP 831,840$31,069,0000.62%
EAM Investors, LLC 55,201$2,056,0000.37%
Dynamic Technology Lab Private Ltd 5,560$207,0000.34%
Polar Capital LLP 350,000$13,038,0000.31%
Old West Investment Management, LLC 10,773$402,0000.24%
View complete list of KYTHERA BIOPHARMACEUTICALS I shareholders